The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

The World Council of Churches has newly published a discussion document: Good News about HIV Treatment, Cure, and Healing: ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

Less than half of those who tested positive for HIV in Pretoria were aware of their HIV status. As such they would not have ...

Health authorities in Rio de Janeiro are reviewing samples from 288 donors after discovering that two HIV-positive people ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

The Dutch Aids foundation Aidsfonds says it is concerned about the rise in cases of HIV in young men who have sex with men.